Identifying Innovation, Impact, and Dislocations in Life Sciences

Kevin Pyun serves as Chief Investment Officer and Managing Partner of Dellora. Prior to forming Dellora in 2020, Mr. Pyun spent 12 years at Consonance Capital Management (“Consonance”), a healthcare-dedicated, long-short equity hedge fund, where he was Partner and Director of Research. Over his tenure at Consonance, Mr. Pyun helped to launch the fund and was responsible for developing and executing the firm’s core investment processes and the eventual build-out and day-to-day management of the firm’s investment research team. Consonance managed over $1.5B at the time of his transition.

Prior to his time at Consonance, Mr. Pyun was a member of the biotechnology equity research team at Morgan Stanley and the life sciences practice of L.E.K. Consulting.

Mr. Pyun holds an MBA in Finance and Healthcare Management from The Wharton School of the University of Pennsylvania and a BA in Biology from the University of Pennsylvania.

Jennifer Teubl, PhD joined Dellora in 2020 and serves as Senior Investment Analyst at the firm. Prior to joining Dellora, Dr. Teubl was a senior research associate at RW Baird where she helped maintain coverage of over 25 small/mid-cap biotech and pharmaceutical companies. Prior to Baird, she held a similar role at B. Riley FBR. Prior to her roles in investment research, Dr. Teubl worked as a statistician for an academic group at the National Development and Research Institute.

Dr. Teubl holds a PhD in Systems and Computational Biomedicine from New York University and a BA from The George Washington University.

Neil Puri, MD joined Dellora in 2023 and serves as Senior Investment Analyst at the firm. Neil is a physician-investor who most recently worked as a healthcare analyst at Altium Capital Management (a healthcare-dedicated long/short fund) and Chief Business Officer at Medicus Sciences Acquisition Corp. Prior to Altium, he was a senior analyst at Alera Partners LP (a healthcare-focused long/short fund), a healthcare investment banker at Jefferies, and a biotechnology equity research associate at both Leerink and BMO Capital Markets. Neil has practiced as a hospitalist at several world class hospitals for years.

Dr. Puri earned his bachelor’s degree in economics at Duke University, his MD at Rutgers/Robert Wood Johnson Medical School, and his MBA from The University of Chicago Booth School of Business.

Jae Park serves as Vice President of Finance and Operations at Dellora.  Prior to joining Dellora, Mr. Park served as the Assistant Controller at Consonance Capital Management (“Consonance”) where he was involved in the firm’s operations and accounting functions.  Prior to his time at Consonance, Mr. Park was an Assistant Controller at Kayne Anderson Capital Advisors.  During his tenure, he helped grow the firm’s back office by creating efficient processes, implementing sound controls, and developing team members as the firm grew from $20B AUM to $30B AUM. 

Mr. Park holds a BA in Economics from Rutgers University.